LSL Pharma Group Inc
XTSX:LSL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Banaras Beads Ltd
NSE:BANARBEADS
|
IN |
|
I
|
Irm Energy Ltd
NSE:IRMENERGY
|
IN |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (11.4), the stock would be worth CA$0.1 (75% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 44.9 | CA$0.42 |
0%
|
| Industry Average | 11.4 | CA$0.1 |
-75%
|
| Country Average | 14.5 | CA$0.13 |
-68%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
L
|
LSL Pharma Group Inc
XTSX:LSL
|
50.3m CAD | 44.9 | 18.1 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
267.2B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 537.2 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.7B ZAR | 14.4 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.3B USD | -18 057 | 38 562.1 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
57.8B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.8B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
33.1B EUR | 67.3 | 175.5 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
37.9B USD | -742.9 | -3 482 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
30.2B ZAR | 17.7 | 7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.6 |
| Median | 14.5 |
| 70th Percentile | 20.6 |
| Max | 3 794.4 |
Other Multiples
LSL Pharma Group Inc
Glance View
LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm specializes in the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms. The firm is also engaged in selling sterile ophthalmic pharmaceutical products.
